Over the past few years, the demand for biotherapeutics has witnessed a significant rise, thanks to the increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, cancer, and multiple sclerosis. This growth in the demand for biotherapeutics, together with the imminent launch of several biopharmaceutical drugs, has created a substantial demand for cell line development.

On the other hand, the strict rules and policies, regulating cell culture procedures in the ... Read more

The global biotherapeutics cell line development market is characterized by a largely consolidated landscape, as the top two players held a sizeable share of 85% of the global market in 2015, finds Transparency Market Research (TMR). These companies are Beckman Coulter and Becton Dickinson and Company. The combined massive share held by these players is increasingly inhibiting the entry ... Read more